Improving prescribing safety in patients with renal insufficiency in the ambulatory setting: The Drug Renal Alert Pharmacy (DRAP) program

Pharmacotherapy

Volumn 31, Issue 4, 2011, Pages 346-356

  Bhardwaja, Bharati ^a,d   Carroll, Nikki M ^b   Raebel, Marsha A ^b,d   Chester, Elizabeth A ^a,d   Korner, Eli J ^c   Rocho, Bob E ^a   Brand, David W ^b   Magid, David J ^b,e  

^a Pharmacy Department   (United States)

^b KAISER PERMANENTE   (United States)

^c GENENTECH INC   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical decision support system; Managed care; Patient safety; Pharmacy practice; Renal

Indexed keywords

ACICLOVIR; ALLOPURINOL; AMANTADINE; CIPROFLOXACIN; COTRIMOXAZOLE; CREATININE; FAMCICLOVIR; GABAPENTIN; GLIBENCLAMIDE; LEVOFLOXACIN; METOCLOPRAMIDE; NITROFURANTOIN; PROCAINAMIDE; SALAZOSULFAPYRIDINE; SPIRONOLACTONE; TRIMETHOPRIM;

ACUTE PYELONEPHRITIS; ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; COMORBIDITY; COMPUTER PROGRAM; CONTROLLED STUDY; CREATININE CLEARANCE; DIALYSIS; DRUG CHOICE; DRUG DOSE; DRUG SAFETY; FEMALE; HUMAN; INTEGRATED HEALTH CARE SYSTEM; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MEDICATION ERROR; OUTPATIENT CARE; PHARMACIST; POPULATION RESEARCH; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; TREATMENT OUTCOME; URINARY TRACT INFECTION;

AMBULATORY CARE; DRUG PRESCRIPTIONS; FORMS AND RECORDS CONTROL; HUMANS; MEDICAL ORDER ENTRY SYSTEMS; MEDICATION ERRORS; PRESCRIPTION DRUGS; RENAL INSUFFICIENCY; TREATMENT OUTCOME;

EID: 79953703126     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.31.4.346     Document Type: Article

References (42)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-47. (Pubitemid 350074801)
2. U.S. Renal Data System. USRDS 2009 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009.
3. Talbert RL. Drug dosing in renal insufficiency. J Clin Pharmacol 1994;34:99-110. (Pubitemid 24079914)
4. Lam YWF, Banerji S, Hatfield C, Talbert RL. Principles of drug administration in renal insufficiency. Clin Pharmacokinet 1997;32:30-57. (Pubitemid 27037847)
5. Kappel J, Calissi P. Nephrology. III. Safe drug prescribing for patients with renal insufficiency. CMAJ 2002;166:473-7. (Pubitemid 34164099)
6. Brenner BM, ed. Brenner and Rector's the kidney, 8th ed [book online]. Philadelphia, PA: Saunders Elsevier; 2008. Available from http://www.mdconsult. com. Accessed March 20, 2009.
7. Matzke GR, Frye RF. Drug administration in patients with renal insufficiency. Drug Saf 1997;16:205-31.
8. Wintersein AG, Hatton RC, Gonzalez-Rothi R, Johns TE, Segal R. Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports. Am J Health Syst Pharm 2002;59:1742-9. (Pubitemid 35033912)
9. Long CL, Raebel MA, Price DW, Magid DJ. Compliance with dosing guidelines in patients with chronic kidney disease. Ann Pharmacother 2004;38:853-8. (Pubitemid 38509067)
10. Wong NACS, Jones HW. An analysis of discharge drug prescribing amongst elderly patients with renal impairment. Postgrad Med J 1998;74:420-2.
11. Cantu TG, Ellerbeck EF, Yun SW, Castine SD, Kornhauser DM. Drug prescribing for patients with changing renal function. Am J Hosp Pharm 1992;49:2944-8.
12. Kai-Ting H, Matayoshi A, Stevenson FT. Calculation of the estimated creatinine clearance in avoiding drugs in the older patient. Am J Med Sci 2001;322:133-6. (Pubitemid 32847824)
13. Papaioannou A, Clarke J, Campbell G, Bedard M. Assessment of adherence to renal dosing guidelines in long-term care facilities. J Am Geriatr Soc 2000;48:1470-3.
14. Pillans PI, Landsberg PG, Fleming AM, Fanning M, Sturtevant JM. Evaluation of dosage adjustment in patients with renal impairment. Intern Med J 2003;33:10-13. (Pubitemid 36241568)
15. Sheen SS, Choi JE, Park RW, Kim EY, Lee YH, Kang UG. Overdose rate of drugs requiring renal dose adjustment: data analysis of 4 years prescriptions at a tertiary teaching hospital. J Gen Intern Med 2007;23:423-8. (Pubitemid 351464857)
16. Yap C, Dunham D, Thompson J, Baker D. Medication dosing errors for patients with renal insufficiency in ambulatory care. Jt Comm J Qual Patient Saf 2005;31:514-21.
17. Frye RF, Matzke GR. Drug therapy individualization for patients with renal insufficiency. In: DiPiro JT, Talbert RL, Yee GC, et al., eds. Pharmacotherapy: a pathophysiological approach, 5th ed. Stamford, CT: Appleton and Lange, 2002:939-52.
18. Aronoff GR, Berns JS, Brier ME, et al. Drug prescribing in renal failure, dosing guidelines for adults, 4th ed. Philadelphia, PA: American College of Physicians, 1999:32, 36, 49, 51-53, 59, 67, 77, 83, 87.
19. Galanter WL, Didomenico RJ, Polikaitis A. A trial of automated decision support alerts for contraindicated medications using computerized physician order entry. J Am Med Inform Assoc 2005;12:269-74. (Pubitemid 40602978)
20. Nash IS, Rojas M, Hebert P, et al. Reducing excessive medication administration in hospitalized adults with renal dysfunction. Am J Med Qual 2005;20:64-9. (Pubitemid 40880394)
21. Chertow GM, Lee J, Kuperman GJ, et al. Guided medication dosing for inpatients with renal insufficiency. JAMA 2001;286:2839-44. (Pubitemid 33126926)
22. Oppenheim MI, Vidal C, Velasco FT, et al. Impact of a computerized alert during physician order entry on medication dosing in patients with renal impairment. Proc AMIA Symp 2002;577-81.
23. Glasgow RE, Vogt TM, Boles SM. Evaluating public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health 1999;89:1322-7. (Pubitemid 29404553)
24. Glasgow RE. Evaluation of theory-based interventions. In: Glanz K, Lewis FM, Rimer BK, eds. Health behavior and health education, 3rd ed. San Francisco, CA: John Wiley & Sons, Inc; 2002: 530-44.
25. Kaiser Permanente Colorado Region Institute for Health Research. The RE-AIM framework. Available from www.reaim.org. Accessed May 7, 2010.
26. Cockcroft DW, Gault HM. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
27. PDR Network. PDRhealth. Available from http://www.pdrhealth.com/home/ home.aspx. Accessed July 23, 2002.
28. Lexi-Comp. Lexi-Comp online. Available from http://www.crclonline.com. Accessed July 23, 2002.
29. Thomson Reuters Healthcare. Micromedex 1.0 healthcare series. Available from http://www.thomsonhc.com. Accessed July 23, 2002.
30. Hooper DC. Urinary tract agents: nitrofurantoin and methenamine. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 5th ed. Philadelphia, PA: Churchill-Livingstone; 2000:424.
31. Long CL, Magid DJ, Raebel MA, Chester EA, Lyons EE. Ambulatory care medication dose adjustments in renal insufficiency: can we do better? [abstract]. Pharmacotherapy 2002;22:1361.
32. Storey JD. A direct approach to false discovery rates. J R Stats Soc B 2002;64:479-98.
33. Raebel MA, Lyons EE, Bodily MA, et al. Improving laboratory monitoring at initiation of drug therapy: a randomized trial. Arch Intern Med 2005;165:2395-401. (Pubitemid 41640852)
34. Raebel MA, Chester EA, Newsom EE, et al. Randomized trial to improve laboratory safety monitoring of drug therapy in ambulatory patients. Pharmacotherapy 2006;26:619-26. (Pubitemid 43673044)
35. Raebel MA, Charles J, Dugan J, et al. Randomized trial to improve prescribing safety among ambulatory elderly patients. J Am Geriatr Soc 2007;55:977-85. (Pubitemid 47024602)
36. Raebel MA, Carroll NM, Kelleher JA, Chester EA, Berga S, Magid DJ. Randomized trial to improve prescribing safety during pregnancy. J Am Med Inform Assoc 2007;14:440-50. (Pubitemid 46963046)
37. Raebel MA, Chester EA, Brand DW, Magid DJ. Imbedding research in practice to improve medication safety. In: Henriksen K, Battles JB, Keyes MA, Grady ML, eds. Advances in patient safety: new directions and alternative approaches. Vol. 4. Technology and medication safety. AHRQ publication no. 08-0034-4. Rockville, MD: Agency for Healthcare Research and Quality; August 2008.
38. Sellier E, Colombet I, Sabatier B, et al. Effect of alerts for drug dosage adjustment in patients with renal insufficiency. J Am Med Inform Assoc 2009;16:203-10.
39. Kuperman GJ, Bobb A, Payne TH, et al. Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc 2007;14:29-40. (Pubitemid 44909484)
40. Falconnier AD, Haefeli WE, Schoenenberger RA, Surber C, Martin-Facklam M. Drug dosage in patients with renal failure optimized by immediate concurrent feedback. J Gen Intern Med 2001;16:369-75. (Pubitemid 34205654)
41. Alaven Pharmaceuticals, LLC. Reglan (metoclopramide) package insert. Marietta, CA; July 2009. Available from http://www.alavenpharm.com/downloads/ ReglanTabletsPI.pdf. Accessed November 11, 2009.
42. Sewell DD, Jeste DV. Metoclopramide-associated tardive dyskinesia. Arch Fam Med 1992;1:271-8.